Companies/SciBase Holding AB
Follow

SciBase Holding AB

Nasdaq First North GM Stockholm (Sweden)

SciBase is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. Its first product, Nevisense, helps clinicians detect melanoma, the most dangerous type of skin cancer. The Company operates in two segments: skin cancer and skin barrier assessment.
Go to market

Sector:
HEALTH CARE
>
Medical Devices
Healthcare
Media
www.scibase.com
Current instruments
Type
Ticker
ISIN
SHARE
SCIB
SE0007045414
Nasdaq First North GM Stockholm Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
SCIB
SE0007045414
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in SciBase Holding AB with ticker SCIB
Status
Active
Currency
SEK
First trading date
02 Jun 2015
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
SCIB
SE0007045414
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in SciBase Holding AB with ticker SCIB
Status
Active
Currency
SEK
First trading date
02 Jun 2015
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
SCIB TO 1
SE0014399689
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in SciBase Holding AB with ticker SCIB TO 1
Status
Archived
Currency
SEK
Trading period
10 Jun 2020 - 14 Oct 2020
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to seventy (70) percent of the volume weighted the average payment price for the Company's share on the Nasdaq First North Growth Market for a period of ten (10) trading days immediately preceding September 30, 2020 (including September 30, 2020), but at least SEK 1 and maximum SEK 1.75 per share. The warrants will be issued free of charge and will be exercisable for subscription of new shares during the period October 5, 2020 until October 16, 2020.
Update (02.10.2020): Exercise price for warrants of series TO1 in SciBase Holding AB determined and the subscription period commence on 5 October 2020.
Exercise
Sign in to buy
People
Simon James Grant
CEO
Tord Bertil Lendau
Chairman of the board
Diana Ferro
Board member
Thomas Taapken
Board member
Barbro Fridén
Board member
Jvalini Dwarkasing
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Landsvägen 39
Zip code
172 63
City/district
Sundbyberg
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
556773-4768
LEI code
549300IY6ZWVN0V2P455
First trade date
02 Jun 2015
Registration date
18 Dec 2008
Short name
SCIB

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More